High-throughput quantitation of SARS-CoV-2 antibodies in a single-dilution homogeneous assay

Abstract SARS-CoV-2 emerged in late 2019 and has since spread around the world, causing a pandemic of the respiratory disease COVID-19. Detecting antibodies against the virus is an essential tool for tracking infections and developing vaccines. Such tests, primarily utilizing the enzyme-linked immun...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Markus H. Kainulainen, Eric Bergeron, Payel Chatterjee, Asheley P. Chapman, Joo Lee, Asiya Chida, Xiaoling Tang, Rebekah E. Wharton, Kristina B. Mercer, Marla Petway, Harley M. Jenks, Timothy D. Flietstra, Amy J. Schuh, Panayampalli S. Satheshkumar, Jasmine M. Chaitram, S. Michele Owen, Laura K. McMullan, Mike Flint, M. G. Finn, Jason M. Goldstein, Joel M. Montgomery, Christina F. Spiropoulou
Format:	article
Langue:	EN
Publié:	Nature Portfolio 2021
Sujets:	Medicine R Science Q
Accès en ligne:	https://doaj.org/article/27dfd414a1384a84aa5cb8b2992de9c1
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Soyez le premier à ajouter un commentaire!

High-throughput quantitation of SARS-CoV-2 antibodies in a single-dilution homogeneous assay

Documents similaires